Molecular-glue-mediated proximity-induced degradation now allows unprecedented therapeutic targeting of previously undruggable proteins. Structures showing how aryl-sulfonamides mediate recruitment of the splicing factor RBM39 to the E3 CRL4DCAF15 broaden the mechanistic principles by which molecular glues target ubiquitylation.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Downregulation of AC092894.1 promotes oxaliplatin resistance in colorectal cancer via the USP3/AR/RASGRP3 axis
BMC Medicine Open Access 03 April 2023
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout

References
Tan, X. et al. Nature 446, 640–645 (2007).
Krönke, J. et al. Science 343, 301–305 (2014).
Lu, G. et al. 343, 305–309 (2014).
Petzold, G., Fischer, E. S. & Thomä, N. H. Nature 532, 127–130 (2016).
Faust, T. et al. Nat. Chem. Biol. https://doi.org/10.1038/s41589-019-0378-3 (2019).
Bussiere, D. E. et al. Nat. Chem. Biol. https://doi.org/10.1038/s41589-019-0411-6 (2019).
Du, X. et al. Structure 27, 1625–1633.e3 (2019).
Han, T. et al. Science 356, eaal3755 (2017).
Uehara, T. et al. Nat. Chem. Biol. 13, 675–680 (2017).
Nowak, R. P. et al. Nat. Chem. Biol. 14, 706–714 (2018).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Baek, K., Schulman, B.A. Molecular glue concept solidifies. Nat Chem Biol 16, 2–3 (2020). https://doi.org/10.1038/s41589-019-0414-3
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41589-019-0414-3
This article is cited by
-
Downregulation of AC092894.1 promotes oxaliplatin resistance in colorectal cancer via the USP3/AR/RASGRP3 axis
BMC Medicine (2023)
-
Pyrrolo[2,1-f][1,2,4]triazine: a promising fused heterocycle to target kinases in cancer therapy
Medicinal Chemistry Research (2022)
-
Targeted degradation of immune checkpoint proteins: emerging strategies for cancer immunotherapy
Oncogene (2020)
-
Anticancer strategies by upregulating p53 through inhibition of its ubiquitination by MDM2
Medicinal Chemistry Research (2020)